Park SJ, Kim HJ, Seo M, Byun DW, et al. Comparative risk of the neurodegenerative outcomes between sodium-glucose co-transporter 2 (SGLT2) inhibitors and thiazolidinediones in type 2 diabetes: a multicentre cohort study using the Korean healthcare database (2014-2025). BMJ Open 2026;16:e105271.
PMID: 41724502